The first of many publications from the C3! Read all about how we got started 📖 Implementing Person-Centered, Clinical, and Research Navigation in Rare Cancers: The Canadian Cholangiocarcinoma Collaborative (C3) https://t.co/9L9IpFTbjK #mdpicurroncol @CurrentOncology

40% liver only and 26% mixed recurrence suggests there might be a benefit to the addition of adjuvant #HAI ⛽️ tx to resected intrahepatic #cholangiocarcinoma @curecc @c3_cholangio

Looking forward to @auer_r speaking about growing hope through research for #NSORD2025 @c3_cholangio @NSHealthHub @BHCRI @curecc @cancercarens

(English below) 💙 Excellente nouvelle ! Le pémigatinib (Pemazyre) est maintenant inscrit à la Liste des médicaments de la RAMQ — ce qui permet aux patients admissibles d’y avoir accès par le régime public. Une grande avancée pour les personnes touchées par le cholangiocarcinome

This October, we stand with everyone affected by liver and bile duct cancers 💚 Through collaboration, research, and advocacy, C3 is helping Canadians get access to testing, trials, and support. Awareness saves lives.

🔥topics in surg onc: HAIP for intrahepatic cholangiocarcinoma by @FlavioRochaMD #ACSCC25 ⛽️PUMP-II trial 🇳🇱 - good response & favourable survival vs historical controls Ongoing HELIX2 trial

🚴‍♀️ Do you like cycling, but hate cancer? Join us this September for the CholangioCycle Challenge (Sept 1–30, 2025) - a Canada-wide bike-a-thon to raise awareness and funds for cholangiocarcinoma research. Donations can be given through our Canadian Cancer Society fundraising

The power of advocacy, persistence, collaboration and hope. Ontarians could get funded access to new rare cancer treatment thanks to Kitchener, Ont. woman’s advocacy https://t.co/EWeO89YwkL @CTVKitchener

🤯 100 Donations! Thank you everyone for raising money to support cholangiocarcinoma research and care 💚🔬🍁 Link in Bio

Good luck to all the marathoners running today's Boston Marathon! Keep an eye out for @danafox, he's running for Hope and raising awareness for #cholangiocarcinoma 💚 Listen to his incredible story from Meet C3 2025 https://t.co/oF5f8LSRr2 via @YouTube

We're on YouTube! 📺 Check out all of the Meet C3 2025 session recordings 💚 Follow and Subscribe 🔔 Link in Bio 🔗 #cholangiocarcinoma #ccahope

Meet C3 Day 1 Recap Highlight Reel! https://t.co/VAYe2h2Pho

Canadians in Utah?!? It must be @curecc ‘s annual conference 💚

#BioCanRx is proud to invest $12.5M in 20 research projects + 4 core facilities to advance #immunotherapy treatments for #cancer and drive Canadian innovation in biotherapeutics! Learn more: https://t.co/HkqpPTWrNu #MadeInCanada

Day 2 - Meet C3 Patient & Caregiver day

Dr. Rebecca Auer @auer_r @OttawaHospital and @c3_cholangio co-founder kicking off #meetC3 inaugural meeting @OICR_news in Toronto 🇨🇦

“For all the cholangiocarcinoma tumor cells out there, we’re coming for you! 💪” Dr. Rebecca Auer #MEETC3 @auer_r

Listening to how @melinda_bachini advocates for #cholangiocarcinoma research and patient care worldwide at #meetc3. Congrats with @ABC interview. Looking forward to working with you next week at conference in Salt Lake City. @c3_cholangio

@ArndtVogel reviewing the clinical trial landscape of #cholangiocarcinoma in 🇨🇦 and beyond @c3_cholangio #meetC3 @curecc

Happy Meet C3 day! Day 1 begins in a few hours (9AM EST) Join us online! 💚 #MeetC3 #cholangiocarcinoma